| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.53 | 0.06 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.13 | 0.06 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.35 | 0.06 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.11 | 0.07 |